AI
LLY icon

AdvisorShares Investments’s Eli Lilly LLY Stock Holding History

AdvisorShares Investments’s Portfolio LLY Stock Details LLY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q1 		– Sell
-2,613
Closed -$956K – 315
2022
Q4 		$956K Buy
+2,613
New +$926K 0.27% 51
2022
Q3 		– Sell
-2,743
Closed -$889K – 332
2022
Q2 		$889K Buy
+2,743
New +$823K 0.25% 43

Other funds holding LLY

Lilly Endowment
Lilly Endowment Indiananapolis, Indiana $108B AUM 53.87% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
PNC Financial Services Group
PNC Financial Services Group Pittsburgh, Pennsylvania $173B AUM 20.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

AdvisorShares Investments's LLY Position: Q1 2023 in Review

AdvisorShares Investments sold out of Eli Lilly (LLY) in Q1 2023, closing a stake of 2,613 shares — an estimated $956K sold.

AdvisorShares Investments first reported a position in LLY in Q2 2022 and held it in 2 quarters. The position peaked at $956K in Q4 2022. 2,615 funds tracked by Wall St. Rank hold LLY as of Q1 2023.

  • AdvisorShares Investments reported no remaining Eli Lilly position as of Q1 2023 after selling out during the quarter.
  • AdvisorShares Investments sold 2,613 Eli Lilly shares in Q1 2023, an estimated $956K.
  • AdvisorShares Investments first reported a position in Eli Lilly in Q2 2022 and held it in 2 quarters.
  • AdvisorShares Investments's Eli Lilly position peaked at $956K in Q4 2022.
  • 2,615 funds tracked by Wall St. Rank held Eli Lilly as of Q1 2023.

Based on AdvisorShares Investments's 13F filing for Q1 2023, filed 9 May 2023.